Animal Health Market is Estimated to Grow at a Evolutionary CAGR of 4.7% During Forecast 2018-2023

Market Highlights:
Animal health is medical term related to the wellbeing of the animals and achieved by efficient prevention and control of animal diseases. it is important with respect to pre-harvest food safety aspects.
The growing pet insurance, rising incidence rate of zoonotic diseases, growing pet population, and spending on animal health are the major factors driving the growth of the global Animal Health Market. Additionally, improvement in productivity, rising focus toward food safety, and increasing pet ownership also fueling the growth of market during forecast periods. For instant, according to the data published in 2016 by the North American Pet Health Insurance Association (NAPHIA), the growth of the pet health insurance in North America was exceeded by 17.2% from 2014 to 2015. Also, In recent years, various government and private associations are working to control zoonotic diseases.
Key Players:
·         Bayer AG
·         Boehringer Ingelheim GmbH
·         Ceva Sante Animale
·         Elanco
·         Eli Lilly
·         Merck Animal Health
·         Nutreco N.V.
·         Vetiquinol SA
·         Virbac
·         Zoeti
Segmentation:
·         The global animal health market has been segmented on the basis of animal type, product, route of administration, and distribution channel.
·         On the basis of animal type, the market has been segmented into farm animal and companion animal. The farm animal segment has been further divided into poultry, swine, cattle, sheep & goats, and others.
·         Based on route of administration, the market has been segmented into oral, parenteral, topical, and others. The market, by distribution channel, has been segmented into veterinary hospitals & clinics, retail, e-commerce, and others.
·          On the basis of animal type farm animal segment is expected to hold the largest market share of the animal health market. Also, vaccines segment to register the significant CAGR in the global animal health market during the forecast period.
Regional Analysis:
The market is likely to dominate by Americas during the forecast period owing to the demand for animal protein, improvement in production, and focus on food safety. Moreover, rising pet ownership and increased medicalization for pets also fueling the growth of the market during forecast periods. The European market is expected to be the second-largest due to government support for research & development and increasing pet population. However, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increased pet adoptions trends, rising population of companion animals, and rise in the number of animal welfare programs. The market in the Middle East & Africa is likely to account for the smallest share of the global animal health market.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more